Using PML nuclear body biology to identify potential AML treatment targets

Project Information

PMLingAML

Grant agreement ID: 843286

DOI 10.3030/843286

Project closed

EC signature date 11 April 2019

Start date 17 December 2020

End date 16 December 2022

Funded under

• EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions

Total cost € 184 707,84

EU contribution € 184 707,84

Coordinated by

INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
France